
Insmed Inc
NASDAQ:INSM

Intrinsic Value
The intrinsic value of one
INSM
stock under the Base Case scenario is
91.11
USD.
Compared to the current market price of 90.93 USD,
Insmed Inc
is
Fairly Valued.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Insmed Inc
Fundamental Analysis

Arikayce drives most of the company’s current revenue, leaving Insmed vulnerable to market changes or competing treatments that could quickly erode its core earnings base.
Continued geographic expansion and potential label extensions for Arikayce could substantially increase its patient reach, reinforcing revenue growth and reducing the company’s reliance on additional funding.

Revenue & Expenses Breakdown
Insmed Inc
Balance Sheet Decomposition
Insmed Inc
Current Assets | 1.4B |
Cash & Short-Term Investments | 1.2B |
Receivables | 47.7m |
Other Current Assets | 155.5m |
Non-Current Assets | 400m |
PP&E | 116.8m |
Intangibles | 193.5m |
Other Non-Current Assets | 89.8m |
Free Cash Flow Analysis
Insmed Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Insmed Inc
Revenue
|
381m
USD
|
Cost of Revenue
|
-89.6m
USD
|
Gross Profit
|
291.5m
USD
|
Operating Expenses
|
-1.2B
USD
|
Operating Income
|
-859m
USD
|
Other Expenses
|
-154.3m
USD
|
Net Income
|
-1B
USD
|
INSM Profitability Score
Profitability Due Diligence
Insmed Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Score
Insmed Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
INSM Solvency Score
Solvency Due Diligence
Insmed Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Score
Insmed Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INSM Price Targets Summary
Insmed Inc
According to Wall Street analysts, the average 1-year price target for
INSM
is 99.07 USD
with a low forecast of 80.8 USD and a high forecast of 114.45 USD.
Dividends
Current shareholder yield for INSM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
INSM
stock under the Base Case scenario is
91.11
USD.
Compared to the current market price of 90.93 USD,
Insmed Inc
is
Fairly Valued.